Alexander A. Fitzpatrick net worth and biography

Alexander Fitzpatrick Biography and Net Worth

Chief Legal Officer of ARS Pharmaceuticals

Alexander A. Fitzpatrick, J.D., has served as our Chief Legal Officer since December 2022. From 2004 through 2022, Mr. Fitzpatrick served as general counsel to several public and private commercial stage pharmaceutical, biotechnology and other technology companies. From 2017 through 2022, Mr. Fitzpatrick served as Executive Vice President, General Counsel and Secretary of Evofem Biosciences, Inc.; from 2014 through 2016, as Chief Legal Officer and Secretary of Kyriba Corporation; from 2010 to 2014 as Senior Vice President, General Counsel, Compliance Officer and Secretary of Verenium Corporation, from 2004 to 2010 as Senior Vice President, General Counsel and Secretary of Kintera, Inc (following the sale of Kintera, Mr. Fitzpatrick continued to serve in a similar position for a major division of Blackbaud, Inc.). Prior to moving in-house, Mr. Fitzpatrick was a member of the business and corporate departments with the law firms Cooley LLP and Latham & Watkins LLP in San Diego, and Rogers & Wells LLP (now Clifford Chance) in London. Mr. Fitzpatrick represented pharmaceutical, healthcare and other technology companies, investment banks and venture capitalists in a variety of transactions including numerous collaborations, mergers and acquisitions, intellectual property matters, licensing and financing activity. Mr. Fitzpatrick received a B.S. in mathematics from Georgetown University and a J.D. from the University of California, Berkeley (Boalt Hall).

What is Alexander A. Fitzpatrick's net worth?: The estimated net worth of Alexander A. Fitzpatrick is at least $536,682.81 as of September 28th, 2023. Mr. Fitzpatrick owns 42,969 shares of ARS Pharmaceuticals stock worth more than $536,683 as of March 29th. This net worth estimate does not reflect any other investments that Mr. Fitzpatrick may own. Additionally, Mr. Fitzpatrick receives an annual salary of $677,140.00 as Chief Legal Officer at ARS Pharmaceuticals. Learn More about Alexander A. Fitzpatrick's net worth.
How old is Alexander A. Fitzpatrick?: Mr. Fitzpatrick is currently 57 years old. There are 6 older executives and no younger executives at ARS Pharmaceuticals. The oldest executive at ARS Pharmaceuticals is Mr. Harris Kaplan M.B.A., Executive Vice President of Commercial Strategy, who is 72 years old. Learn More on Alexander A. Fitzpatrick's age.
What is Alexander A. Fitzpatrick's salary?: As the Chief Legal Officer of ARS Pharmaceuticals, Inc., Mr. Fitzpatrick earns $677,140.00 per year. There are 2 executives that earn more than Mr. Fitzpatrick. The highest earning executive at ARS Pharmaceuticals is Mr. Richard Lowenthal M.B.A., M.S., MSMSEL, Founder, President, CEO & Director, who commands a salary of $2,750,000.00 per year. Learn More on Alexander A. Fitzpatrick's salary.
How do I contact Alexander A. Fitzpatrick?: The corporate mailing address for Mr. Fitzpatrick and other ARS Pharmaceuticals executives is 500 Fairview Ave N Suite 600, Seattle WA, 98109. ARS Pharmaceuticals can also be reached via phone at 206-456-2900 and via email at ir@silverbacktx.com. Learn More on Alexander A. Fitzpatrick's contact information.
Has Alexander A. Fitzpatrick been buying or selling shares of ARS Pharmaceuticals?: Alexander A. Fitzpatrick has not been actively trading shares of ARS Pharmaceuticals during the last quarter. Most recently, on Thursday, September 28th, Alexander A. Fitzpatrick bought 40,000 shares of ARS Pharmaceuticals stock. The stock was acquired at an average cost of $3.62 per share, with a total value of $144,800.00. Following the completion of the transaction, the insider now directly owns 42,969 shares of the company's stock, valued at $155,547.78. Learn More on Alexander A. Fitzpatrick's trading history.
Who are ARS Pharmaceuticals' active insiders?: ARS Pharmaceuticals' insider roster includes Justin Chakma (Chief Business Officer), Brian Dorsey (Chief Operating Officer), Alexander Fitzpatrick (Chief Legal Officer), Eric Karas (Chief Commercial Officer), Richard Lowenthal (President and Chief Executive Officer), Kathleen Scott (Chief Financial Officer), Laura Shawver (Director), Sarina Tanimoto (Chief Medical Officer), and Peter Thompson (Director). Learn More on ARS Pharmaceuticals' active insiders.
Are insiders buying or selling shares of ARS Pharmaceuticals?: In the last twelve months, insiders at the sold shares 37 times. They sold a total of 2,961,053 shares worth more than $39,496,274.18. The most recent insider tranaction occured on March, 20th when insider Eric Karas sold 10,000 shares worth more than $140,000.00. Insiders at ARS Pharmaceuticals own 40.1% of the company. Learn More about insider trades at ARS Pharmaceuticals.
Information on this page was last updated on 3/20/2025.

Alexander A. Fitzpatrick Insider Trading History at ARS Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/28/2023	Buy	40,000	$3.62	$144,800.00	42,969

Alexander A. Fitzpatrick Buying and Selling Activity at ARS Pharmaceuticals

ARS Pharmaceuticals Company Overview

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.

Today's Range

Now: $12.49

$12.21

$12.78

50 Day Range

MA: $12.15

$10.18

$14.88

2 Week Range

Now: $12.49

$7.55

$18.51

Volume

1,191,077 shs

Average Volume

1,074,219 shs

Market Capitalization

$1.23 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03

Alexander Fitzpatrick Biography and Net Worth

What is Alexander A. Fitzpatrick's net worth?

How old is Alexander A. Fitzpatrick?

What is Alexander A. Fitzpatrick's salary?

How do I contact Alexander A. Fitzpatrick?

Has Alexander A. Fitzpatrick been buying or selling shares of ARS Pharmaceuticals?

Who are ARS Pharmaceuticals' active insiders?

Are insiders buying or selling shares of ARS Pharmaceuticals?